The entity has a beta of 4.36, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Vicarious Surgical will likely underperform. At this point, Vicarious Surgical has a negative expected return of -1.35%. Please make sure to validate Vicarious Surgical's maximum drawdown, as well as the relationship between the daily balance of power and period momentum indicator , to decide if Vicarious Surgical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak
Strong
Over the last 90 days Vicarious Surgical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2026. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
Vicarious Surgical Relative Risk vs. Return Landscape
If you would invest 546.00 in Vicarious Surgical on September 26, 2025 and sell it today you would lose (350.00) from holding Vicarious Surgical or give up 64.1% of portfolio value over 90 days. Vicarious Surgical is currently does not generate positive expected returns and assumes 7.491% risk (volatility on return distribution) over the 90 days horizon. In different words, 67% of stocks are less volatile than Vicarious, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
Expected Return
Risk
Given the investment horizon of 90 days Vicarious Surgical is expected to under-perform the market. In addition to that, the company is 10.52 times more volatile than its market benchmark. It trades about -0.18 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of volatility.
Vicarious Surgical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vicarious Surgical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Vicarious Surgical, and traders can use it to determine the average amount a Vicarious Surgical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1806
Best Portfolio
Best Equity
Good Returns
Average Returns
Small Returns
Cash
Small Risk
Average Risk
High Risk
Huge Risk
Negative Returns
RBOT
Based on monthly moving average Vicarious Surgical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vicarious Surgical by adding Vicarious Surgical to a well-diversified portfolio.
Vicarious Surgical Fundamentals Growth
Vicarious Stock prices reflect investors' perceptions of the future prospects and financial health of Vicarious Surgical, and Vicarious Surgical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Vicarious Stock performance.
Assessing Vicarious Surgical's fundamental ratios provides investors with valuable insights into Vicarious Surgical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Vicarious Surgical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts. Vicarious Surgical operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 153 people.
Things to note about Vicarious Surgical performance evaluation
Checking the ongoing alerts about Vicarious Surgical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Vicarious Surgical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Vicarious Surgical generated a negative expected return over the last 90 days
Vicarious Surgical may become a speculative penny stock
Vicarious Surgical has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (63.22 M) with profit before overhead, payroll, taxes, and interest of 0.
Vicarious Surgical currently holds about 126.8 M in cash with (49.96 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.04.
Vicarious Surgical has a frailfinancial position based on the latest SEC disclosures
Roughly 20.0% of the company outstanding shares are owned by corporate insiders
Evaluating Vicarious Surgical's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Vicarious Surgical's stock performance include:
Analyzing Vicarious Surgical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Vicarious Surgical's stock is overvalued or undervalued compared to its peers.
Examining Vicarious Surgical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
Evaluating Vicarious Surgical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Vicarious Surgical's management team can help you assess the Company's leadership.
Pay attention to analyst opinions and ratings of Vicarious Surgical's stock. These opinions can provide insight into Vicarious Surgical's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Vicarious Surgical's stock performance is not an exact science, and many factors can impact Vicarious Surgical's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Additional Tools for Vicarious Stock Analysis
When running Vicarious Surgical's price analysis, check to measure Vicarious Surgical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vicarious Surgical is operating at the current time. Most of Vicarious Surgical's value examination focuses on studying past and present price action to predict the probability of Vicarious Surgical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vicarious Surgical's price. Additionally, you may evaluate how the addition of Vicarious Surgical to your portfolios can decrease your overall portfolio volatility.